APG Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,300
| Closed | -$3.8M | – | 548 |
|
|
2025
Q1 | $3.8M | Sell |
27,300
-2,804
| -9% | -$470K | 0.01% | 477 |
|
|
2024
Q4 | $5.37M | Buy |
30,104
+22,349
| +288% | +$4.31M | 0.01% | 452 |
|
|
2024
Q3 | $1.37M | Sell |
7,755
-53,262
| -87% | -$11.1M | 0.01% | 346 |
|
|
2024
Q2 | $11.8M | Buy |
61,017
+6,258
| +11% | +$1.42M | 0.02% | 389 |
|
|
2024
Q1 | $13.7M | Buy |
54,759
+16,277
| +42% | +$3.89M | 0.02% | 389 |
|
|
2023
Q4 | $8.24M | Sell |
38,482
-2,726
| -7% | -$536K | 0.02% | 425 |
|
|
2023
Q3 | $8.08M | Sell |
41,208
-4,549
| -10% | -$934K | 0.02% | 432 |
|
|
2023
Q2 | $8.82M | Sell |
45,757
-24
| -0.1% | -$4.78K | 0.02% | 425 |
|
|
2023
Q1 | $8.5M | Sell |
45,781
-7,592
| -14% | -$1.72M | 0.02% | 440 |
|
|
2022
Q4 | $11.6M | Buy |
53,373
+43,282
| +429% | +$9.45M | 0.02% | 432 |
|
|
2022
Q3 | $2.03M | Buy |
10,091
+3,298
| +49% | +$712K | 0.01% | 546 |
|
|
2022
Q2 | $1.39M | Buy |
6,793
+4,293
| +172% | +$1.05M | ﹤0.01% | 603 |
|
|
2022
Q1 | $638K | Sell |
2,500
-100
| -4% | -$30.8K | ﹤0.01% | 777 |
|
|
2021
Q4 | $861K | Sell |
2,600
-1,300
| -33% | -$505K | ﹤0.01% | 747 |
|
|
2021
Q3 | $1.39M | Sell |
3,900
-1,900
| -33% | -$789K | ﹤0.01% | 686 |
|
|
2021
Q2 | $1.81M | Buy |
+5,800
| New | +$1.94M | ﹤0.01% | 673 |
|
|
2018
Q3 | – | Sell |
-128,800
| Closed | -$12.4M | – | 853 |
|
|
2018
Q2 | $12.4M | Sell |
128,800
-138,800
| -52% | -$15M | 0.02% | 453 |
|
|
2018
Q1 | $23.2M | Sell |
267,600
-101,200
| -27% | -$10.9M | 0.04% | 326 |
|
|
2017
Q4 | $33.6M | Buy |
368,800
+266,700
| +261% | +$29M | 0.06% | 303 |
|
|
2017
Q3 | $11M | Buy |
+102,100
| New | +$10.5M | 0.02% | 506 |
|
Other funds holding CRL
AI
